Evidence map›Paper›PMID 40726780›Full record

ArticleACS central science2025

Peptide and Protein Cyclization by a Promiscuous Graspetide Synthetase.

Brian Choi, Toby G Johnson, Arthur Acuña, Hader E Elashal, A James Link

Abstract read
In one paragraph

Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Repositioning the Leader Peptide in Graspetide Biosynthesis.Journal of the American Chemical Society · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brian ChoiDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States.ORCID https://orcid.org/0000-0003-2976-8577
Toby G JohnsonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States.ORCID https://orcid.org/0000-0002-6475-769X
Arthur AcuñaDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States.
Hader E ElashalDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States.ORCID https://orcid.org/0000-0002-8073-2628
A James LinkDepartment of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States.ORCID https://orcid.org/0000-0001-5066-9691

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocyclic peptides have drawn considerable interest as modalities for drug discovery. Graspetides are a class of ribosomally synthesized and post-translationally modified peptides (RiPPs) that harbor one or more macrocycles. These macrocycles are built via side chain-side chain linkages that are installed by ATP-grasp enzymes, giving the peptide family their name. We recently reported on the discovery, structure, and biosynthesis of the graspetide pre-fuscimiditide which is comprised of a stem covalently linked by two ester moieties and a 10 aa loop. Here we probe the substrate tolerance of the fuscimiditide ATP-grasp enzyme, ThfB, and show that it is highly promiscuous. ThfB can cyclize substrates with substitutions to or extensions of the stem region as well as generate multivalent cyclic structures. ThfB also shows remarkable tolerance to substitutions in the loop of pre-fuscimiditide. Loops comprised of flexible glycine-serine sequences ranging from 4 aa to 72 aa were efficiently cyclized by ThfB. Even substrates in which full-length proteins were swapped for the 10 aa loop of pre-fuscimiditide could be cyclized by ThfB. We also show that ThfB can covalently cross-link supramolecularly assembled protein chains. These data show that ThfB is a highly generalizable biocatalyst for both peptide and protein macrocyclization as well for intermolecular protein cross-linking.

Identifiers

PMID40726780
PMCPMC12291112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.